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Abstract
Background GATA6, a transcription factor expressed in cholangiocytes, has been implicated in the response to liver injury. 
In biliary atresia, a disease characterized by extrahepatic bile duct obstruction, liver expression of GATA6 increases with 
pathological bile duct expansion and decreases after successful Kasai portoenterostomy. The aim of this study was to garner 
genetic evidence that GATA6 is involved in ductular formation/expansion.
Methods The murine Gata6 gene was conditionally deleted using Alb-cre, a transgene expressed in hepatoblasts (the pre-
cursors of hepatocytes and cholangiocytes) and mature hepatocytes. Bile duct ligation (BDL) was used to model biliary 
obstruction.
Results Alb-Cre;Gata6flox/flox mice were viable and fertile. Cre-mediated recombination of Gata6 in hepatocytes had little 
impact on cellular structure or function. GATA6 immunoreactivity was retained in a majority of biliary epithelial cells in adult 
Alb-Cre;Gata6flox/flox mice, implying that surviving cholangiocytes were derived from hepatoblasts that had escaped biallelic 
Cre-mediated recombination. Although GATA6 immunoreactivity was preserved in cholangiocytes, Alb-cre;Gata6flox/flox 
mice had a demonstrable biliary phenotype. A neutrophil-rich infiltrate surrounded newly formed bile ducts in neonatal Alb-
Cre;Gata6flox/flox mice. Foci of fibrosis/necrosis, presumed to reflect patchy defects in bile duct formation, were observed in 
the livers of 37% of adult Alb-cre;Gata6flox/flox mice and 0% of controls (p < 0.05). Most notably, Alb-cre;Gata6flox/flox mice 
had an altered response to BDL manifest as reduced survival, impaired bile ductule proliferation, increased parenchymal 
necrosis, reduced fibrosis, and enhanced macrophage accumulation in the portal space.
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Introduction
The two principal liver cell types, hepatocytes and chol-
angiocytes, derive from foregut (definitive) endoderm [7, 
11]. At embryonic day (E) 9.0 in the mouse, hepatoblasts 
delaminate from foregut endoderm and invade the adjacent 
septum transversum, forming the liver bud [7]. Hepatoblasts 
proliferate and then differentiate into hepatocytes and chol-
angiocytes, a process that begins at ~ E12.5 and continues 
through the balance of gestation [7]. Underscoring their 
bipotential nature, hepatoblasts express markers of both 
hepatocytes [albumin (ALB)] and cholangiocytes [cytoker-
atin 19 (CK19)] [7]. The differentiation of cholangiocytes 
initiates at the ductal plate, a monolayer of cells surround-
ing the portal vein [7]. Cholangiocyte precursors, which 
express higher levels of CK19 and SRY-related HMG box 
transcription factor 9 (SOX9) than adjoining hepatoblasts, 
bud from the ductal plate to form primitive tubular struc-
tures [12, 17]. Shortly after birth, these structures integrate 
with portal mesenchyme to form mature bile ducts [25]. 
The differentiation of intrahepatic bile ducts begins in the 
hilum of the liver and progresses toward its periphery [25]. 
Whereas cholangiocytes lining intrahepatic bile ducts derive 
from hepatoblasts, cholangiocytes in extrahepatic bile ducts 
arise directly from definitive endoderm through branching 
morphogenesis [25].
Although normally quiescent in adults, intrahepatic bile 
ducts can undergo adaptive remodeling following liver 
injury [9, 17]. A histopathological hallmark of this com-
pensatory response is ductular reaction (DR), different forms 
of which occur in a range of hepatobiliary diseases [11, 20]. 
Extrahepatic biliary obstruction elicits a classic form of 
DR characterized by accumulation of primitive bile duct-
ules, intermediate hepatobiliary cells, inflammatory cells, 
and collagen within the portal tract [1]. Ductular expansion 
serves to limit the toxic effects of excessive bile accumula-
tion within the parenchyma as evidenced by the pronounced 
liver damage seen in mouse models with impaired DR [10, 
17]. The cellular origin of reactive bile ductules is not fully 
understood [11]; some of the cholangiocytes in these new 
ductules arise from mitosis, but hepatocytes also can give 
rise to cholangiocytes via direct lineage conversion (meta-
plasia or transdifferentiation) [16, 21].
One of the transcription factors involved in liver cell dif-
ferentiation and the response to injury is GATA6, a mem-
ber of a family of zinc finger proteins that regulate cell fate 
specification in many tissues [14]. Gata6 is expressed in 
definitive endoderm and hepatoblasts of the liver bud [29]. 
Gata6−/− mice die during gastrulation due to defects in 
primitive endoderm [29], so the role of this transcription 
factor in liver function cannot be deduced from these ani-
mals. Through tetraploid embryo complementation, a means 
of circumventing defects in primitive endoderm function, 
investigators have shown that GATA6 is essential for liver 
bud formation and expansion in the mouse [29]. Later in 
gestation, liver expression of Gata6 becomes restricted to 
non-hepatocyte cell populations, mainly cholangiocytes, 
endothelial cells, and Kupffer cells [23, 30]. Viral-mediated 
silencing of Gata6 in hepatocytes of the adult mouse has 
little impact on liver histology or gene expression, imply-
ing that GATA6 is dispensable in this cell type [30]. On the 
other hand, emerging evidence suggests that this transcrip-
tion factor is important for cholangiocyte differentiation and 
bile duct development. Heterozygous loss-of-function muta-
tions in human GATA6 cause gallbladder agenesis and other 
extrahepatic biliary malformations [5]. In biliary atresia, a 
disease characterized by obstruction of extrahepatic bile 
ducts, liver GATA6 expression increases with pathological 
intrahepatic bile duct expansion and decreases after success-
ful Kasai portoenterostomy [23]. Gata6 is upregulated dur-
ing de novo transdifferentiation of hepatocytes into cholangi-
ocytes in a mouse model of Alagille syndrome [21, 23], and 
forced expression of GATA6 in cultured human hepatocytes 
induces expression of cholangiocyte lineage markers [23].
Although GATA6 has been implicated in cholangiocyte 
differentiation and bile duct proliferation, much of the evi-
dence is circumstantial. Here, we use Cre-LoxP technology 
to probe the role of GATA6 in hepatobiliary pathophysiol-
ogy in an animal model. We show that conditional deletion 
of the murine Gata6 gene using Alb-cre disrupts intrahepatic 
bile duct development and the response to bile duct ligation 
(BDL).
Methods
Experimental animals and surgical procedures
Gata6flox/flox mice [22] (Jackson Laboratory, 129.B6 back-
ground) were crossed with Alb-cre transgenic mice [19] 
(Washington University core, C57Bl/6 background) to gen-
erate Alb-cre;Gata6flox/+ mice, which were then backcrossed 
to Gata6flox/flox mice to yield Alb-cre;Gata6flox/flox mice. Mice 
were genotyped using established PCR primers [19, 22]. 
Mice were euthanized by  CO2 asphyxiation. Serum samples 
were collected via cardiac puncture immediately after death. 
Two-thirds partial hepatectomy (PHx) was performed [8] 
on 2-months-old male Gata6flox/flox and Alb-cre;Gata6flox/flox 
mice. Tissue was harvested 36 h after surgery; 1 h prior to 
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harvest, mice were injected with 5-bromo-2′-deoxyuridine 
(BrdU, 100 mg/kg intraperitoneally) [12]. BDL or sham 
surgery (incision/suturing of the skin and peritoneum) 
was performed on 2-months-old Gata6flox/flox and Alb-
cre;Gata6flox/flox mice [24]. Following surgery, mice were 
monitored by technicians who were blinded to genotype. 
Mice subjected to BDL or sham surgery were euthanized 
after 14 days; animals exhibiting signs of distress were euth-
anized earlier. At the conclusion of the experiment, mice 
were examined for gross anatomical evidence that BDL was 
a technical success [gallbladder enlargement, biloma forma-
tion, jaundice, and liver enlargement/texture], and tissue was 
harvested for analysis.
Histological analyses
Tissues were fixed overnight in 4% paraformaldehyde (PFA) 
in PBS. Paraffin-embedded tissue sections (5 μm) were pre-
pared and stained with H&E, Masson’s trichrome, or Sirius 
red. For histomorphometric analysis, images were gener-
ated using a 3DHISTECH Pannoramic 250 FLASH II digital 
slide scanner. Fibrosis was quantified as a percentage of Sir-
ius red stained area compared with total section area. Areas 
of necrosis were quantified in trichrome-stained sections in a 
similar manner. Paraformaldehyde-fixed, paraffin-embedded 
tissue sections were immunostained using an avidin–biotin 
immunoperoxidase system (Vector Laboratories) or fluores-
cent antibodies [18]. The primary and secondary antibodies 
used for each antigen are listed in Table S1. BrdU labeling 
and  CK19+ areas were quantified as described [10].
Electron microscopy
Mice were anesthetized and then perfused with modified 
Karnovsky fixative via a needle inserted into the left ventri-
cle [18]. Tissue was harvested and processed for transmis-
sion electron microscopy [30].
Serum chemistry measurements
Serum alanine aminotransferase (ALT), total bilirubin (as 
diazo derivative), and albumin (as bromocresol green com-
plex) were measured on a Roche c501 chemistry platform. 
Whole blood glucose levels were determined by handheld 
glucometer (Arkray).
Genomic PCR to assess the Cre‑mediated 
recombination
DNA was extracted from liver and subjected to PCR using 
a set of primers that discriminate wild-type, floxed, and 
recombined alleles [22]. Hepatocytes were isolated as 
described [8].
Quantitative RT‑PCR (RT‑qPCR)
RNA was isolated from liver and subjected to RT-qPCR 
analysis [8] using the primers in Table S2. Expression was 
normalized to the housekeeping genes Gapdh, Actb, and 
Ppig.
Statistical methods
Data are expressed as mean ± SE. Statistical significance 
was determined using the Student’s t test (two-tailed) except 
where otherwise noted.
Results
Generation of Alb‑cre;  Gata6flox/flox mice
Consistent with prior reports [23, 30] we observed nuclear 
GATA6 immunostaining in cholangiocytes, as evidenced by 
co-localization with SOX9, within small and large intrahe-
patic bile ducts of both adult (Fig S1A, S2) and neonatal 
(Fig S3A, B) mice. Variable GATA6 immunoreactivity was 
seen in endothelial cells and Kupffer cells (Fig S3A, B) but 
hepatocytes were devoid of GATA6 staining (Fig S1A).
To investigate the role of GATA6 in hepatobiliary devel-
opment and function, we generated liver-specific knockout 
mice using an Alb-cre transgene [19] and a floxed Gata6 
allele [22] (Fig S1B). Cre-mediated recombination of 
Gata6flox deletes exon 2, yielding a functionally null allele 
(Gata6Δ). Rosa26 reporter (R26R) experiments have shown 
that Alb-cre is expressed stochastically in hepatoblasts, lead-
ing to recombination of floxed alleles in a subset of these 
bipotential precursors of hepatocytes and cholangiocytes 
[16]. Alb-cre expression persists in fetal and postnatal hepat-
ocytes, resulting in extensive Cre-mediated recombination 
in this cell type by 6 weeks of age [28]. Alb-cre expression 
is extinguished in cholangiocytes, but Alb-cre;R26R lineage 
tracing studies have shown that a preponderance of cholan-
giocytes in adult mice derive from hepatoblasts that have 
undergone Cre-LoxP recombination [16, 28]. Therefore, 
Alb-cre is suitable for targeting gene deletion in both hepato-
cytes and cholangiocytes, although the extent of Cre-LoxP 
recombination in cholangiocytes varies depending on the 
floxed gene [16, 28]. Alb-cre is not active in other lineages 
such as sinusoidal endothelial cells or Kupffer cells.
Male and female Alb-cre;Gata6flox/flox mice were born at 
the expected Mendelian frequencies in two separate crosses 
(Fig S1C). The conditional knockout mice appeared healthy 
and survived to adulthood with normal growth (Fig S4). 
When mated with proven breeders, male and female Alb-
cre;Gata6flox/flox mice produced normal sized litters (9–11 
pups).
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Extent of Cre‑mediated recombination 
in hepatocytes vs. cholangiocytes
To confirm Cre-mediated deletion of Gata6, we subjected 
DNA isolated from liver extracts of adult mice to PCR using 
primers that distinguish intact and recombined (Gata6Δ) 
alleles (Fig S1B). We detected Gata6Δ in the livers of Alb-
cre;Gata6flox/+ and Alb-cre;Gata6flox/flox mice, but not Gata-
6flox/flox mice (data not shown). PCR of DNA isolated from 
purified hepatocytes yielded similar results (Fig S5).
To assess the extent of Cre-mediated recombination in 
cholangiocytes, we performed immunostaining for GATA6 
on liver tissue from 2-months-old Alb-cre;Gata6flox/flox mice 
(Fig S6A, B). Adjacent tissue sections were stained with 
CK19 to highlight cholangiocytes (Fig S6C, D). Notably, 
GATA6 immunoreactivity was detected in the vast major-
ity of cholangiocytes, including those in large ducts near 
the liver hilum and in smaller ducts near the periphery. 
Thus, most of the surviving cholangiocytes in adult Alb-
cre;Gata6flox/flox mice were derived from hepatoblasts that 
had escaped biallelic deletion of Gata6 (Fig S6E). Although 
GATA6 immunoreactivity was preserved in the majority of 
cholangiocytes in Alb-cre;Gata6flox/flox mice, there was nev-
ertheless a demonstrable hepatobiliary phenotype in neo-
natal and adult Alb-cre;Gata6flox/flox mice, as detailed in the 
following sections and summarized in Table S3.
Transient inflammation accompanies bile duct 
maturation in newborn Alb‑cre;  Gata6flox/flox mice
At E15.5, SOX9 immunostaining delineated ductal plate 
cells (nascent cholangiocytes) in both Gata6flox/flox and Alb-
cre;Gata6flox/flox liver (Fig. 1a, b). These SOX9-immunore-
active cells were GATA6-negative (Fig. 1c, d), suggesting 
that GATA6 may not be crucial for the earliest phases of 
cholangiocyte differentiation. By P2, GATA6 immunoreac-
tivity was evident in cholangiocytes of Gata6flox/flox (Fig. 1e), 
implying that this gene is upregulated in biliary epithelial 
cells between E15.5 and P2, which coincides with bile duct 
formation/maturation.
Interestingly, a prominent infiltrate of inflammatory cells 
surrounded newly formed bile ducts in Alb-cre;Gata6flox/flox 
mice but not littermate Gata6flox/flox mice (Fig. 1e–g). The 
infiltrate, which contained many myeloperoxidase-positive 
neutrophils, was morphologically distinct from islands 
of extramedullary hematopoiesis that typify this stage 
of liver development. These findings suggest that when 
Gata6 upregulation is impaired by gene targeting, inflam-
mation ensues. Neonatal jaundice was not evident in the 
Alb-cre;Gata6flox/flox mice, indicating that bile flow was not 
severely compromised in these animals. By P30, this peri-
ductal inflammatory infiltrate resolved (Fig S7), and at P75 
serum total bilirubin levels were below the limit of detection 
(< 0.1 mg/dL) in adult Gata6flox/flox and Alb-cre;Gata6flox/flox 
mice (n = 10 each).
Thus, mosaic inactivation of Gata6 at the hepatoblast 
stage of development leads to transient inflammation in the 
bile ducts of newborn mice. The appearance of the neutro-
phil-rich infiltrate in Alb-cre;Gata6flox/flox mice coincides 
with the normal upregulation of Gata6 in maturing bile 
ducts, suggesting that GATA6 modulates intrahepatic biliary 
remodeling in newborn mice.
Focal histological abnormalities in the livers 
of 2‑months‑old Alb‑cre;  Gata6flox/flox mice
In a majority of young adult Alb-cre;Gata6flox/flox mice, the 
liver appeared normal when examined by H&E staining or 
trichrome staining (Fig. 2a–d). At the ultrastructural level 
(Fig. 2e–f), hepatocytes and cholangiocytes exhibited nor-
mal polarization and cell-to-cell contacts. The apical sur-
faces of adjacent hepatocytes formed bile canaliculi, struc-
tures that facilitate the transport of newly secreted bile to 
cholangiocyte-lined bile ducts. Along their basolateral sur-
face, hepatocytes were separated from adjoining sinusoidal 
endothelial cells by the space of Disse, the site at which sub-
stances are exchanged between plasma and hepatocytes. The 
apical poles of cholangiocytes contained junctional com-
plexes and primary cilia, structures that control mechanico- 
and chemo-sensing.
Two indicators of hepatocyte function, serum albu-
min (Fig. 2g) and whole blood glucose (Fig.  2h), were 
indistinguishable in young adult Alb-cre;Gata6flox/flox and 
Gata6flox/flox mice. There was no difference in expression 
of hepatocyte-specific transcripts (Alb, Cebpb) between 
the conditional knockout and control mice (Fig. 2i). Col-
lectively, these results suggest that silencing of Gata6 in 
hepatocytes has no substantial effect on basal function, in 
agreement with a previous report [30]. To extend the func-
tional analysis of hepatocytes, we subjected 2-months-old 
Gata6flox/flox and Alb-cre;Gata6flox/flox mice to two-thirds 
Fig. 1  Gata6 expression is induced in cholangiocytes around the 
time of birth, and conditional deletion of Gata6 triggers a periductu-
lar infiltrate in neonatal liver. Liver sections from E15.5 (a–d) or P2 
(e–h) mice of the indicated genotypes were stained with antibody 
against SOX9 (a, b), GATA6 (c–f), or myeloperoxidase (MPO) (g, 
h).  SOX9+ ductal plate cells (arrowheads in a) were evident in both 
Gata6flox/flox and Alb-cre;Gata6flox/flox mice. In contrast, there was 
no discernible GATA6 staining in the ductal plate cells of either 
strain. GATA6 staining in cardiac atrial cells served as an inter-
nal positive control (insets, c, d). At P2,  GATA6+ cholangiocytes 
were observed in both Gata6flox/flox and Alb-cre;Gata6flox/flox mice. 
An inflammatory infiltrate composed mainly of  MPO+ neutrophils 
(arrow in f) surrounded newly formed bile ducts in 4 of 4 (100%) Alb-
cre;Gata6flox/flox mice but was absent from 4 littermate Gata6flox/flox 
mice (p < 0.01, two populations proportions testing). The insets in 
panels g and h show smaller bile ducts in the periphery. at atrium, b 
bile duct, v portal vein. Bars = 20 µm
◂
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PHx, an established model of regenerative stress. Tissue was 
harvested 36 h after PHx (Fig S8A), a time point normally 
associated with a brisk hepatocyte proliferative response 
[8]. Gata6flox/flox and Alb-cre;Gata6flox/flox mice had similar 
liver to body weight ratios at baseline and post-PHx (Fig 
S8B). There were no differences in post-PHx blood glucose 
levels between Gata6flox/flox and Alb-cre;Gata6flox/flox mice 
(Fig S8C). Moreover, hepatocyte BrdU labeling index, a 
Fig. 2  Histological, ultrastructural, and biochemical analysis of liv-
ers from P75 Alb-cre;Gata6flox/flox mice. a–d Liver sections from 
Alb-cre;Gata6flox/flox mice were stained with H&E or trichrome. 
The majority (5/8 = 63%) of Alb-cre;Gata6flox/flox mouse livers were 
indistinguishable from those of control mice (n = 13); the remain-
der (3/8 = 37%) had isolated patches of portal fibrosis with cholesta-
sis (arrows) or hepatocyte necrosis (*, inset). Abbreviation: v, portal 
vein. Bars = 40  µm. e–f Transmission electron microscopy of Alb-
cre;Gata6flox/flox mouse liver (n = 3). Normal-appearing hepatocytes 
abut an endothelial cell-lined sinusoid (e). Note the presence of bile 
canaliculi (apical hepatocyte membrane) and the peri-sinusoidal 
space of Disse (basolateral hepatocyte membrane). Normal appear-
ing cholangiocytes line a bile duct (f). Junctional complexes between 
adjacent cholangiocytes and a primary cilium are highlighted. 
Bars = 2 µm (left), 1 µm (right), 0.4 µm (inset). g Serum albumin lev-
els in P75 Gata6flox/flox (n = 11) and Alb-cre;Gata6flox/flox mice (n = 5 
per group). h Blood glucose levels (n = 5 per group). i RT-qPCR 
analysis of the hepatocyte markers Alb and Cebpb, the cholangiocyte 
marker Ck19, and the macrophage marker Adgre in P75 mice Gata-
6flox/flox (n = 11) and Alb-cre;Gata6flox/flox mice (n = 6). J) Serum ALT 
levels. Dashed lines indicate the mean. None of these biochemical 
parameters differed significantly between conditional knockout and 
control mice
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measure of proliferation, was similar in Gata6flox/flox and 
Alb-cre;Gata6flox/flox mice (Fig S8D-F). The cholangiocyte 
BrdU labeling index was reduced in the Alb-cre;Gata6flox/flox 
mice, although the difference was not significant (p = 0.27, 
Student’s t-test) (Fig S8F). The absence of a PHx phenotype 
in Alb-cre;Gata6flox/flox mice serves as a counterpoint to the 
robust BDL phenotype described below.
Although adult liver function appeared intact in the 
aforementioned experiments, isolated foci of portal fibrosis, 
hepatocyte necrosis, or mild DR were observed in the livers 
of 3/8 (37%) young adult Alb-cre;Gata6flox/flox mice (Fig. 2b, 
d; Fig S9). By comparison, no lesions were observed in 13 
age-matched control (Gata6flox/flox) mice (p < 0.05, two-pop-
ulations-proportion-testing). Within affected livers, these 
foci of fibrosis/necrosis were rare, constituting < 5% of the 
liver cross sectional area. The focal liver lesions in adult 
Alb-cre;Gata6flox/flox mice may reflect patchy defects in intra-
hepatic bile duct development. At 2 months of age, serum 
ALT activity, an indicator of hepatocyte injury, did not dif-
fer significantly between Gata6flox/flox vs. Alb-cre;Gata6flox/flox 
mice (Fig. 2j).
Aberrant response to BDL in Alb‑cre;  Gata6flox/flox 
mice
In patients with biliary atresia, liver GATA6 expression cor-
relates with pathological intrahepatic bile duct expansion 
[23]. Whether GATA6 is essential for this process is unclear. 
To assess the impact of Gata6 deletion on the response 
to extrahepatic bile duct obstruction, 2-months-old Alb-
cre;Gata6flox/flox or control (Gata6flox/flox) mice were subjected 
to BDL. Tissue and blood samples were analyzed 14-days 
later (Fig. 3a). Studies of wild-type mice have shown that 
the acute cholestasis caused by BDL elicits a stereotypical 
response that includes necroinflammation, cholangiocyte 
proliferation, intermediate cell activation, and fibrosis [1, 
Fig. 3  Alb-cre;Gata6flox/flox mice exhibit increased hepatic necrosis 
and decreased survival following BDL. a Adult (2-months-old) Gata-
6flox/flox or Alb-cre;Gata6flox/flox mice were subjected to BDL or sham 
surgery and monitored for 14 days by technicians who were blinded 
to genotype. Mice exhibiting signs of distress were euthanized before 
day 14 and scored as non-survivors. b, c BDL resulted in gallblad-
der dilation (indigo arrows) and biloma formation in both Gata6flox/flox 
and Alb-cre;Gata6flox/flox mice, but only Alb-cre;Gata6flox/flox mice had 
large patches of liver necrosis (white arrow) evident on gross exami-
nation at day 14. d, e Kaplan–Meier curves comparing post-BDL sur-
vival of Gata6flox/flox (solid line) and Alb-cre;Gata6flox/flox (dashed line) 
mice. Sham surgery survival was 100% for both strains (not shown). 
The inset of panel d shows a dot plot of post-BDL serum total biliru-
bin levels for the Gata6flox/flox and Alb-cre;Gata6flox/flox mice that sur-
vived 14 days. Horizontal dashed lines in the inset indicate the mean 
serum total bilirubin levels. Some of the survivors had only modest 
elevations in serum total bilirubin levels (< 6  mg/dL, red circles), 
suggesting that BDL may have been incomplete in these animals. 
When these mice were censored in a post hoc analysis (e), there was 
still a marked difference in post-BDL survival between Gata6flox/flox 
and Alb-cre;Gata6flox/flox mice. Prepared using image vectors from 
Servier Medical Art (www.servi er.com), licensed under the Creative 
Commons Attribution 3.0 Unported License (http://creat iveco mmons 
.org/licen se/by/3.0/)
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24]. Following BDL interlobular bile ducts undergo adap-
tive remodeling, wherein in the intraluminal surface area 
is expanded via corrugation and branching [27]. Gata6 is 
expressed in these reactive bile ductules [23].
Consistent with published reports for wild-type mouse 
strains [1], Gata6flox/flox mice had a 14-day post-BDL sur-
vival rate of 88% (Fig.  3d). In contradistinction, Alb-
cre;Gata6flox/flox mice had a 14-day post-BDL survival rate of 
only 50% (Fig. 3d, p = 0.014, Gehen-Breslow-Wilcoxon test). 
Some of the surviving Gata6flox/flox and Alb-cre;Gata6flox/flox 
mice had only modest elevations in serum total bilirubin lev-
els (< 6 mg/dL), suggesting that BDL may have been incom-
plete in these animals (Fig. 3d, inset). When these mice were 
censored in a post hoc analysis (see legend), there was still 
a marked difference in post-BDL survival between Gata-
6flox/flox and Alb-cre;Gata6flox/flox mice (Fig. 3e, p = 0.009, 
Gehen-Breslow-Wilcoxon test). As expected, BDL liga-
tion resulted in gallbladder dilation ± biloma formation in 
both Gata6flox/flox and Alb-cre;Gata6flox/flox mice (Fig. 3b, c). 
Post-BDL liver to body weight ratios did not differ between 
Gata6flox/flox and Alb-cre;Gata6flox/flox mice (7.60 ± 0.29% and 
7.63 ± 0.48%, respectively), but the conditional knockout 
mice had large patches of liver necrosis evident on gross 
examination (Fig. 3b vs. c). Massive areas of liver necrosis 
were observed in Alb-cre;Gata6flox/flox mice that died within 
a week of BDL (Fig S10).
H&E, GATA6, and CK19 staining of post-BDL liver 
sections demonstrated an abundance of reactive bile duct-
ules in the portal regions of Gata6flox/flox mice (Fig. 4a–c). 
In contrast, there was a paucity of  CK19+ neoductules in 
Alb-cre;Gata6flox/flox mice (Fig. 4d), and the ductules that 
did form were irregular [N.B., we define neoductules newly 
formed ductular structures within the portal space that 
express CK19, SOX9, and proliferation markers (Ki-67 or 
BrdU)]. Reactive cholangiocytes in Alb-cre;Gata6flox/flox 
mice had a reduced Ki67 labeling index (Fig. 5a, b), suggest-
ing that GATA6 deficiency negatively impacts cholangiocyte 
proliferation in response to BDL. Following BDL, there was 
a prominent infiltrate of macrophages in the portal region 
of Alb-cre;Gata6flox/flox vs. Gata6flox/flox mice, as highlighted 
by F4/80 immunostaining (Fig. 5c), 1 µm epoxy sections 
(Fig. 5e), and transmission electron microscopy (Fig S11). 
Corroborating the immunohistochemical findings, RT-qPCR 
demonstrated reduced expression of two cholangiocyte 
markers (Ck19 and EpCAM; Fig. 4e) and increased expres-
sion of the macrophage marker Adgre (encoding F4/80 anti-
gen; Fig. 5d) in post-BDL liver of Alb-cre;Gata6flox/flox vs. 
Gata6flox/flox mice.
Next, we examined the post-BDL liver specimens for the 
presence of intermediate cells, which are defined as cells 
exhibiting both hepatocytic and biliary differentiation in dis-
eased liver [11]. BDL is known to induce the expression of 
Sox9, a cholangiocyte marker, in periportal hepatocytes of 
wild-type mice [11]. SOX9 immunoreactivity was evident 
in periportal hepatocytes (arrowheads) of both Gata6flox/flox 
and Alb-cre;Gata6flox/flox mice (Fig S12). That Gata6 target-
ing attenuates post-BDL CK19 immunoreactivity (Fig. 4c, 
d) but not SOX9 immunoreactivity is in keeping with an 
earlier report showing that forced expression of GATA6 in 
primary human hepatocytes induces expression of CK19 but 
not SOX9 [23].
To quantify the extent of baseline and reactive fibrosis, 
we performed Sirius red staining of collagen on sham and 
BDL mice (Fig. 6a–d). Consistent with published reports for 
wild-type mice [1, 24], BDL triggered a marked increase in 
fibrosis in Gata6flox/flox mouse liver (Fig. 6e). On the other 
hand, BDL elicited no significant change in fibrosis in Alb-
cre;Gata6flox/flox mouse. Using histomorphometric analysis, 
we documented increased parenchymal necrosis in the liv-
ers of Alb-cre;Gata6flox/flox mice, both pre- and post-BDL 
(Fig S13). The measured degree of necrosis in livers of 
Alb-cre;Gata6flox/flox mice is an underestimate, because we 
intentionally did not make tissue sections through large, 
confluent areas of necrosis (Fig. 3c). Despite these histo-
logical differences, post-BDL serum total bilirubin levels 
were comparable in Gata6flox/flox (11.7 ± 5.6 mg/dL) and 
Alb-cre;Gata6flox/flox (11.1 ± 4.3 mg/dL) animals (p = 0.68; 
Fig. 3d, inset).
In summary, we found that Alb-cre;Gata6flox/flox mice have 
an altered response to BDL that includes decreased survival, 
reduced bile ductule proliferation, pronounced parenchymal 
necrosis, increased macrophage infiltration, and decreased 
fibrosis. Our analysis of the impact of BDL included both 
male and female mice. No significant sex variation was 
observed in the survival or histological response of Alb-
cre;Gata6flox/flox mice to BDL (data not shown).
Discussion
GATA6, a transcription factor expressed in definitive endo-
derm and hepatoblasts, is crucial for the earliest stages 
of liver development. GATA6 is known to bind and acti-
vate genes necessary for endoderm differentiation, and 
Fig. 4  Abnormal histological and biochemical response to BDL 
in Alb-cre;Gata6flox/flox mice. Adult (2-months-old) Gata6flox/flox 
or Alb-cre;Gata6flox/flox mice were subjected to BDL or sham sur-
gery, and tissue was harvested 14 days later for analysis. H&E (a), 
GATA6 (b), and CK19 (c) immunostaining demonstrated numerous 
reactive bile ductules (arrowheads) in the portal regions of Gata-
6flox/flox but not Alb-cre;Gata6flox/flox mice. Consistent with the immu-
nostaining results, RT-qPCR demonstrated reduced expression of 
the cholangiocyte markers Ck19 and EpCAM (e) in post-BDL liver 
of Alb-cre;Gata6flox/flox mice (n = 7–11 per group). Histomorphomet-
ric analysis (d) confirmed reduced CK19 immunoreactivity in Alb-
cre;Gata6flox/flox mice (n = 5 per group). b bile duct, n necrosis, v por-
tal vein. Bars = 50 µm (a), 25 µm (b), 75 µm (c). (*p < 0.05)
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modulation of GATA6 expression has been shown to affect 
in vitro differentiation of human pluripotent stem cells into 
various endoderm derivatives, including liver parenchy-
mal cells [6, 15, 26]. Tetraploid embryo complementation 
experiments have proven that GATA6 is required for liver 
bud formation and expansion [29], but the resultant embryos 
do not survive beyond ~ E11, precluding an assessment of 
later aspects of hepatic development such as cholangiocyte 
differentiation and bile duct formation.
To investigate the role of GATA6 in postnatal liver 
development and function, we generated and analyzed 
Alb-cre;Gata6flox/flox mice. Cre-mediated recombination in 
hepatocytes of Alb-cre;Gata6flox/flox mice had little impact 
on hepatocyte function in young adult mice, as evidenced 
by normal levels of serum albumin and an intact regenera-
tive response to PHx. This confirms and extends an ear-
lier report showing that viral-mediated silencing of Gata6 
in hepatocytes of the adult mouse had minimal effects on 
gene expression [30]. Although hepatocellular function was 
preserved in Alb-cre;Gata6flox/flox mice, these animals had 
a demonstrable biliary phenotype first manifest at P2 as a 
neutrophil-rich inflammatory infiltrate surrounding newly 
formed bile ducts. Later, isolated foci of parenchymal 
fibrosis/necrosis, presumed to reflect patchy defects in the 
Fig. 5  Impaired cholangiocyte proliferation and increased mac-
rophage infiltration following BDL in Alb-cre;Gata6flox/flox mice. 
Adult (2-months-old) Gata6flox/flox or Alb-cre;Gata6flox/flox mice were 
subjected to BDL or sham surgery, and tissue was harvested 14 days 
later for analysis. Reactive cholangiocytes in Alb-cre;Gata6flox/flox 
mice had reduced Ki67 immunoreactivity compared to controls (a, 
b) (n = 5 per group). F4/80 immunostaining (c) and 1 µm epoxy sec-
tions (e) showed increased macrophages (arrows) in the portal region 
of Alb-cre;Gata6flox/flox mice. Consistent with the immunostaining 
results, RT-qPCR demonstrated increased expression of the mac-
rophage marker Adgre (d) in post-BDL liver of Alb-cre;Gata6flox/flox 
mice (n = 7–11 per group). b bile duct, h hepatocyte, v portal vein. 
Bars = 25 µm (a, c), 20 µm (e). (*p < 0.05; ***p < 0.005)
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biliary tree, were observed in the livers of a subset of adult 
Alb-cre;Gata6flox/flox mice. Most strikingly, the conditional 
knockout mice had an altered response to BDL that included 
an impaired DR, increased hepatic necrosis, and decreased 
survival. These findings are reminiscent of another geneti-
cally-engineered mouse model in which impaired DR was 
associated with submassive hepatic necrosis and increased 
mortality after BDL [10], supporting the premise that adap-
tive remodeling of bile ducts helps contain the accumulation 
of bile acids following acute biliary obstruction. We pro-
pose that upregulation of Gata6 in neoductules is required to 
compensate for obstructed bile flow and minimize acute liver 
injury (inflammation and infarcts) and that impaired survival 
post-BDL reflects inadequate bile duct expansion to protect 
the parenchyma. Taken together, our studies establish that 
GATA6 plays a role in intrahepatic biliary development and 
biliary epithelial tissue expansion/remodeling in response 
to injury. Our findings are in keeping with a recent analy-
sis of tissue samples from patients with biliary atresia [23], 
wherein GATA6 was implicated in the reparative response 
to hepatobiliary damage. Although BDL is a widely used 
experimental model of biliary obstruction and fibrosis, it 
has limitations. Notably, the reactive cholangiocytes in this 
model derive mainly from proliferation of mature cholan-
giocytes in larger bile ducts rather than from activation of 
bipotential liver progenitor cell populations, and the latter is 
thought to underlie the pathobiology of many human hepa-
tobiliary diseases. Moreover, focal abnormalities in bile duct 
development may exacerbate the post-BDL phenotype of 
adult Alb-cre;Gata6flox/flox mice.
Analysis of mice harboring germline or conditional muta-
tions in transcription factor genes has yielded insights into 
biliary morphogenesis, a complex process driven by coor-
dinated cell–cell interactions [7]. Transcriptional regulators 
crucial for intrahepatic bile duct development or remodeling 
include HNF6, HNF1β, C/EBPα, FOXM1, SOX4, SOX9, 
KLF5, and NFκB [2, 4, 13, 17]. These factors work in 
concert with key signaling pathways such as the NOTCH, 
TGFβ, and Hippo/YAP pathways [3, 10, 20]. Based on 
our findings, GATA6 can be added to this list of transcrip-
tion factors, although it may not be crucial for the earliest 
aspects of biliary development given the limited expression 
of Gata6 detected in the ductal plate. Interestingly, many 
of the growth factors and transcription factors involved in 
formation of the biliary epithelium during embryonic life are 
reactivated in adulthood in response to liver injury [11]. Our 
results suggest that GATA6 participates in the gene regula-
tory networks that underlie DR. Moreover, our findings rein-
force the notion that transcription factors involved in injury 
repair recapitulate those required for biliary ontogenesis.
Although the findings presented here establish a role for 
GATA6 in biliary development and the response to extrahe-
patic biliary obstruction, the mechanistic underpinnings of 
the Alb-cre;Gata6flox/flox phenotype are less clear. Potential 
mechanisms include: (1) a decrease in the number of pro-
liferating hepatoblasts, (2) a cell-autonomous defect in the 
differentiation of GATA6-deficient hepatoblasts into chol-
angiocytes, (3) impaired survival of GATA6-deficient chol-
angiocytes, (4) a cell-autonomous defect in lineage conver-
sion of GATA6-deficient hepatocytes into cholangiocytes, 
and (5) altered cell–cell interactions or impaired production 
of secreted factors by liver cells. Also, a haploinsufficiency 
effect is theoretically possible, but germline Gata6± mice do 
not have a known liver phenotype.
The cellular origin of reactive bile ductules remains an 
area of active investigation and controversy. Under certain 
circumstances, murine hepatocytes can undergo lineage 
Fig. 6  Decreased BDL-induced fibrosis in Alb-cre;Gata6flox/flox mice. 
Adult (2-months-old) Gata6flox/flox or Alb-cre;Gata6flox/flox mice were 
subjected to sham surgery (a, b) or BDL (c, d). Tissue was harvested 
14 d later and stained with Sirius red to quantify collagen content (e, 
n = 5–7 per group). As expected, BDL induced fibrosis in Gata6flox/flox 
mice. In contrast, BDL did not elicit fibrosis in Alb-cre;Gata6flox/flox 
mice. Bars = 40 µm. (*p < 0.05)
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conversion into cholangiocytes [16, 21]. Previously we sug-
gested that GATA6, which is upregulated in periportal hepat-
ocytes of children with biliary atresia, may drive hepatocyte-
cholangiocyte lineage conversion in humans [23]. Likewise, 
Gata6 has been shown to be induced in periportal hepato-
cytes in mouse models of DR, including BDL [23]. A recent 
study showed that Gata6 expression is upregulated 4.3-fold 
during de novo transdifferentiation of hepatocytes into 
hepatocyte-derived peripheral cholangiocytes in a mouse 
model of Alagille syndrome [21]. Therefore, the impaired 
DR seen in Alb-cre;Gata6flox/flox mice post-BDL might be 
attributed to deletion of Gata6 from hepatocytes undergoing 
lineage conversion. Arguing against this, a fate tracing study 
in mice showed that cholangiocytes generated in response to 
selective ligation of the left hepatic duct do not derive from 
hepatocytes [16].
Altogether, we conclude that GATA6, among other 
factors, orchestrates intrahepatic biliary remodeling and 
mitigates liver injury following extrahepatic bile duct 
obstruction.
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